These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3768722)

  • 1. Behavioral effects of a single neuroleptic treatment grow with the passage of time.
    Antelman SM; Kocan D; Edwards DJ; Knopf S; Perel JM; Stiller R
    Brain Res; 1986 Oct; 385(1):58-67. PubMed ID: 3768722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One experience with 'lower' or 'higher' intensity stressors, respectively enhances or diminishes responsiveness to haloperidol weeks later: implications for understanding drug variability.
    Antelman SM; Caggiula AR; Kocan D; Knopf S; Meyer D; Edwards DJ; Barry H
    Brain Res; 1991 Dec; 566(1-2):276-83. PubMed ID: 1814544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
    Ossowska K; Karcz M; Wardas J; Wolfarth S
    Eur J Pharmacol; 1990 Jul; 182(2):327-34. PubMed ID: 1975782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.
    Karoum F; Egan MF
    Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute versus chronic haloperidol: relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release.
    Osborne PG; O'Connor WT; Beck O; Ungerstedt U
    Brain Res; 1994 Jan; 634(1):20-30. PubMed ID: 7908848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An animal model of extrapyramidal side effects induced by antipsychotic drugs: relationship with D2 dopamine receptor occupancy.
    Crocker AD; Hemsley KM
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):573-90. PubMed ID: 11370998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective effects of buspirone and molindone on dopamine metabolism and function in the striatum and frontal cortex of the rat.
    McMillen BA; McDonald CC
    Neuropharmacology; 1983 Mar; 22(3):273-8. PubMed ID: 6133232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of dopamine metabolism in rat brain frontal cortex: a common effect of chronically administered antipsychotic drugs.
    Mefford IN; Roth KA; Agren H; Barchas JD
    Brain Res; 1988 Dec; 475(2):380-4. PubMed ID: 2905626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of a strong influence of neuroleptic decanoates on dopaminergic and GABAergic functions.
    Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(2):99-107. PubMed ID: 8688897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.
    Rivest R; Marsden CA
    Br J Pharmacol; 1991 Sep; 104(1):234-8. PubMed ID: 1786513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain.
    Karolewicz B; Antkiewicz-Michaluk L; Michaluk J; Vetulani J
    Eur J Pharmacol; 1996 Oct; 313(3):181-6. PubMed ID: 8911913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalepsy induced by striatal acetylcholinesterase inhibition with fasciculin in rats.
    Castelló ME; Bolioli B; Dajas F
    Pharmacol Biochem Behav; 1992 Mar; 41(3):547-50. PubMed ID: 1584833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensification of cataleptic response in 6-hydroxydopamine-induced neurodegeneration of substantia nigra is not dependent on the degree of dopamine depletion.
    Srinivasan J; Schmidt WJ
    Synapse; 2004 Mar; 51(3):213-8. PubMed ID: 14666519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.
    Ichikawa J; Meltzer HY
    Brain Res; 1990 Jan; 507(1):138-42. PubMed ID: 2302571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One brief exposure to a psychological stressor induces long-lasting, time-dependent sensitization of both the cataleptic and neurochemical responses to haloperidol.
    Antelman SM; Kocan D; Knopf S; Edwards DJ; Caggiula AR
    Life Sci; 1992; 51(4):261-6. PubMed ID: 1625517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures.
    Coyle S; Napier TC; Breese GR
    Brain Res; 1985 Nov; 355(1):27-38. PubMed ID: 4075104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditioned tolerance to haloperidol- and droperidol-induced catalepsy.
    Nowak K; Welsch-Kunze S; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):385-91. PubMed ID: 3405313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum.
    Rivest R; Marsden CA
    Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone.
    Nakai S; Hirose T; Uwahodo Y; Imaoka T; Okazaki H; Miwa T; Nakai M; Yamada S; Dunn B; Burris KD; Molinoff PB; Tottori K; Altar CA; Kikuchi T
    Eur J Pharmacol; 2003 Jul; 472(1-2):89-97. PubMed ID: 12860477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents.
    Gentzel RC; Toolan D; Roberts R; Koser AJ; Kandebo M; Hershey J; Renger JJ; Uslaner J; Smith SM
    Neuropharmacology; 2015 Dec; 99():256-63. PubMed ID: 26044638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.